Single shot for psoriasis? study probes why some see lasting relief
Knowledge-focused
Ongoing
This study aims to understand why a single dose of the psoriasis drug risankizumab (Skyrizi) can lead to long-term skin clearance for some people, even after stopping treatment. Researchers will analyze skin samples from 20 adults with moderate-to-severe psoriasis to see how the …
Phase: PHASE4 • Sponsor: Jaehwan Kim • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC